Novel Organism Verification and Analysis (NOVA) study: identification of 35 clinical isolates representing potentially novel bacterial taxa using a pipeline based on whole genome sequencing

Background Reliable species identification of cultured isolates is essential in clinical bacteriology. We established a new study algorithm named NOVA – N ovel O rganism V erification and A nalysis to systematically analyze bacterial isolates that cannot be characterized by conventional identification procedures MALDI-TOF MS and partial 16 S rRNA gene sequencing using Whole Genome Sequencing (WGS). Results We identified a total of 35 bacterial strains that represent potentially novel species. Corynebacterium sp. (n = 6) and Schaalia sp. (n = 5) were the predominant genera. Two strains each were identified within the genera Anaerococcus , Clostridium , Desulfovibrio , and Peptoniphilus , and one new species was detected within Citrobacter , Dermabacter , Helcococcus , Lancefieldella , Neisseria , Ochrobactrum (Brucella) , Paenibacillus , Pantoea , Porphyromonas , Pseudoclavibacter , Pseudomonas , Psychrobacter , Pusillimonas , Rothia , Sneathia , and Tessaracoccus . Twenty-seven of 35 strains were isolated from deep tissue specimens or blood cultures. Seven out of 35 isolated strains identified were clinically relevant. In addition, 26 bacterial strains that could only be identified at the species level using WGS analysis, were mainly organisms that have been identified/classified very recently. Conclusion Our new algorithm proved to be a powerful tool for detection and identification of novel bacterial organisms. Publicly available clinical and genomic data may help to better understand their clinical and ecological role. Our identification of 35 novel strains, 7 of which appear to be clinically relevant, shows the wide range of undescribed pathogens yet to define.